ES447803A2 - Procedimiento de obtencion de un activador del plasminogeno. - Google Patents

Procedimiento de obtencion de un activador del plasminogeno.

Info

Publication number
ES447803A2
ES447803A2 ES447803A ES447803A ES447803A2 ES 447803 A2 ES447803 A2 ES 447803A2 ES 447803 A ES447803 A ES 447803A ES 447803 A ES447803 A ES 447803A ES 447803 A2 ES447803 A2 ES 447803A2
Authority
ES
Spain
Prior art keywords
plasminogen activator
pharmaceutical compositions
activator pharmaceutical
preparing
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES447803A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of ES447803A2 publication Critical patent/ES447803A2/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES447803A 1975-05-05 1976-05-05 Procedimiento de obtencion de un activador del plasminogeno. Expired ES447803A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7513932A FR2310133A2 (fr) 1975-05-05 1975-05-05 Nouveau medicament comportant un activateur du plasminogene perfectionne

Publications (1)

Publication Number Publication Date
ES447803A2 true ES447803A2 (es) 1977-07-01

Family

ID=9154824

Family Applications (1)

Application Number Title Priority Date Filing Date
ES447803A Expired ES447803A2 (es) 1975-05-05 1976-05-05 Procedimiento de obtencion de un activador del plasminogeno.

Country Status (6)

Country Link
US (1) US4083961A (es)
BE (1) BE841251R (es)
DE (1) DE2619667C2 (es)
ES (1) ES447803A2 (es)
FR (1) FR2310133A2 (es)
GB (1) GB1551275A (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462165A2 (fr) * 1973-12-03 1981-02-13 Fabre Sa Pierre Procede perfectionne de preparation d'activateur du plasminogene
GB2121050B (en) * 1979-07-05 1986-03-26 Genentech Inc Preparation of functional human urokinase proteins
CA1154671A (fr) * 1979-07-27 1983-10-04 Lucien D. D'hinterland Separation d'un activateur tissulaire du plasminogene
FR2483234A2 (fr) * 1980-05-29 1981-12-04 Fabre Sa Pierre Composition ophtalmique contenant un activateur du plasminogene
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
US5112755A (en) * 1982-04-15 1992-05-12 Genentech, Inc. Preparation of functional human urokinase proteins
US4853330A (en) * 1983-04-07 1989-08-01 Genentech, Inc. Human tissue plasminogen activator
SU1662352A3 (ru) * 1982-05-05 1991-07-07 Генентек, Инк (Фирма) Штамм бактерий ЕSснеRIснIа coLI - продуцент активатора плазминогена тканевого типа
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
FI831484L (fi) * 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3512908A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Gewebe-plasminogenaktivator (t-pa) enthaltendes mittel
US5120715A (en) * 1988-12-12 1992-06-09 Takeda Chemical Industries, Ltd. Method for purifying fibroblast growth factor protein
US6207151B1 (en) * 1989-09-21 2001-03-27 Mitsui Chemicals Inc. Aqueous solution of t-PA
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
US5288489A (en) * 1991-08-28 1994-02-22 Orion Therapeutic Systems, Inc. Fibrinolysis and fibrinogenolysis treatment
AU2006200638B2 (en) * 1999-10-01 2007-11-01 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6440414B1 (en) * 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6261820B1 (en) * 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
AU2004201694B2 (en) * 1999-10-01 2006-03-02 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US7033776B2 (en) 1999-12-17 2006-04-25 Amgen Inc. Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2153200A1 (en) * 1971-09-24 1973-05-04 Choay Sa Stable,pyrogen-free urokinase prepns - from human urine

Also Published As

Publication number Publication date
FR2310133B2 (es) 1978-12-01
BE841251R (fr) 1976-10-28
FR2310133A2 (fr) 1976-12-03
US4083961A (en) 1978-04-11
GB1551275A (en) 1979-08-30
DE2619667A1 (de) 1976-11-18
DE2619667C2 (de) 1984-12-06

Similar Documents

Publication Publication Date Title
ES447803A2 (es) Procedimiento de obtencion de un activador del plasminogeno.
HU173317B (hu) Sposob poluchenija anilidov furankarbonovojj kisloty i mikrobicidnye kompozicii soderzhahhie ikh aktivnymi agentami
IL46760A0 (en) Novel 2-tetrahydrofurfuryl-6,7-benzomorphane derivatives,their production and pharmaceutical compositions containing them
HU171219B (hu) Sposob poluchenija azolil-amidinov i gerbicidnye kompozicii soderzhahhie ikh aktivnym agentom
IL47877A0 (en) Novel thienothiazine derivatives,their manufacture and pharmaceutical compositions containing them
IL47735A (en) 8a-substituted-6-alkyl-ergoline i derivatives,their production and pharmaceutical compositions containing them
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
ES434431A1 (es) Procedimiento para preparar derivados del xanteno.
IL47404A0 (en) Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them
HU174010B (hu) Sposob poluchenija 1-alkil-2-skobka-fenoksimetil-skobka zakryta-5-nitro-imidazolov i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
IL48054A0 (en) New vincanol derivatives,their production and pharmaceutical compositions containing them
IL47623A0 (en) Novel pharmaceutical compositions
IL46707A0 (en) Phenylbutanol derivatives,process for their preparation and compositions containing them
IL48527A0 (en) New 7,7-diphenyl-hexahydro-1,4-oxazepines,their manufacture and pharmaceutical compositions containing them
FR2290203B1 (es)
IL46890A0 (en) New-1-aryl-uracils,their production and pharmaceutical compositions containing them
IL48239A0 (en) Novel d-homosteroids,their manufacture and pharmaceutical compositions containing them
HU171537B (hu) Sposob poluchenija novykh slozhnykh efirov 5-n-butil-piridin-2-karbonovojj kisloty i kompozicijj soderzhahhikh ikh aktivnym agentom
IL47085A0 (en) Ergoline compounds,their production and pharmaceutical compositions containing them
HU175697B (hu) Sposob poluchenija proizvodnykh beta-laktama i farmacevticheskikh komozicijj soderzhahhikh ikh aktivnymi agentami
IL48603A (en) 4-phenyl-4-hydroxyhexyhydroindole derivatives, their production and pharmaceutical compositions containing them
IL46553A0 (en) Naphthyridene derivatives,their production and pharmaceutical compositions containing them
IL47263A (en) 3s-methyl-7-nitro-5-phenyl-2h-1,4-benzodiazepine-2-ones, their manufacture and pharmaceutical compositions containinthem
IL48219A0 (en) Novel steroids,their manufacture and pharmaceutical compositions containing them
IL48607A0 (en) Novel beta-lactams,their preparation and pharmaceutical compositions containing them